The fibroblasts growth factor 21 study in patients with non-alcoholic fatty liver disease and hypertension comorbidities

by O. Ya. Babak, K. A. Lapshyna
Published 2020-04-01

Assessment of cardiac hemodynamics indicators in patients with arterial hypertension and non-alcoholic fatty liver disease depending on angiotensin II type 1 receptor A1166C gene p...

by O. Ya. Babak, M. M. Zaitseva
Published 2018-06-01

Dynamics of daily blood pressure monitoring in hypertensive patients with obesity exposed to combined anthihypertensive therapy

by O. Ya. Babak, K. I. Tereshkin, V. V. Shkolnik
Published 2013-10-01

Effect of Genetic Polymorphism on the Formation of Nonalcoholic Fatty Liver Disease

by O.Ya. Babak, Ye.V. Kolesnikova, І.V. Shut, Ye.G. Кurinnaya, К.A. Sytnic
Published 2013-02-01